<DOC>
	<DOCNO>NCT01981941</DOCNO>
	<brief_summary>To evaluate safety , efficacy pharmacokinetics gabapentin enacarbil moderate severe primary RLS patient moderate renal impairment confirm dosage administration population .</brief_summary>
	<brief_title>Post-marketing Study Gabapentin Enacarbil Evaluate Effect Restless Leg Syndrome ( RLS ) Patients With Moderate Renal Impairment</brief_title>
	<detailed_description>This study multicenter , non-blinded , non-comparative study . Patients meet eligible criterion undergo one week observation period follow four week treatment period . In treatment period , patient receive gabapentin enacarbil orally one daily dinner . After four-week treatment period gabapentin enacarbil , one-week post-observation period undertaken .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Patients diagnose restless legs syndrome ( RLS ) accord international RLS Study Group Diagnostic Criteria Patients whose score 15 great International RLS ( IRLS ) Rating Scale first day preobservation period . Patients whose creatinine clearance level first day preobservation period â‰¥30 mL/min &lt; 60mL/min estimate CockcroftGaul equation Patients provide write consent Patients sleep disorder sleep apnea syndrome , affect RLS evaluation Patients history augmentation treatment rebound RLS symptom use dopamine agonis Patients neuropathy movement disorder ( diabetic neuropathy , Parkinson 's disease , multiple sclerosis , dyskinesia , rheumatoid arthritis etc ) Patients uncontrolled diabetes [ HbA1c &gt; 7.5 % ( NGSP value ) , past six month ] , iron deficiency anemia , drug administration hypnotic sedative . Patients attempt suicide within six month prior consent obtain , diagnose suicide risk investigator subinvestigator Patients moderate severe depression Patients alcohol dependence drug intoxication history abuse drug dependence past one year Patients whose job shift work , professional driver , engage hazardous activity operate machinery Patients history hypersensitivity gabapentin Patients experience participate postmarketing clinical study clinical trial within 12 week prior start preobservation Others : patient conclude ineligible investigator subinvestigator ineligible</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Gabapentin</keyword>
	<keyword>Restless legs syndrome ( RLS )</keyword>
</DOC>